세계 뉴로이미징 시장 : 기술별, 용도별, 최종 사용자별, 이미지 유형별, 지역별
Neuroimaging Market, By Technology, By Application, By End-User, By Image Type, By Geography
상품코드
:
1378572
리서치사
:
Coherent Market Insights
발행일
:
2023년 09월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
뉴로이미징 시장 규모는 2023년 376억 3,000로 평가되었고, 2030년에는 565억 8,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR) 6%를 나타낼 전망입니다.
| 보고 범위 |
보고서 세부정보 |
| 기준년 |
2022년 |
2023년 시장 규모 |
376억 3,000만 달러 |
| 업적 데이터 |
2018년-2021년 |
예측 기간 |
2023-2030 |
| 예측 기간의 복합 연간 성장률(CAGR) |
6.00% |
2030년 시장 규모 예측 |
565억 8,000만 달러 |
그림 1. 세계 뉴로이미징 시장 점유율(%), 지역별(2030년)
뉴로이미징은 뇌의 구조와 기능을 시각화하는 의료 이미지의 한 분야입니다. 다양한 질병과 장애의 근본적인 신경학적 과정과 이상에 대한 귀중한 인사이트을 제공합니다. 이 기술은 신경과학 분야에 혁명을 일으켜 인간의 뇌를 이해하는 데 크게 기여합니다.
시장 역학:
뉴로이미징 시장은 여러 요인에 의해 견인되고 있습니다. 첫째, 신경 질환의 유병률이 증가함에 따라 정확한 진단 도구에 대한 수요가 높아지고 뉴로이미징 기술의 채택으로 이어지고 있습니다. 또한 자기 공명영상법(MRI), 양전자방사단층촬영법(PET), 컴퓨터단층촬영법(CT) 등의 영상기술의 진보로 뇌영상 해상도와 정밀도가 크게 향상되었습니다. 신경 영상 진단 장치의 고가의 비용과 그에 따른 보수 및 운용 비용이 특히 개발 도상 지역에서의 접근성을 제한하고 있습니다. 또한 CT 스캔에서 전리 방사선 노출과 같은 특정 영상 진단 기술의 안전성에 대한 우려는 시장 성장에 어려움을 겪고 있습니다. 그래도 뉴로이미징 시장에는 몇 가지 기회가 있습니다. 기능적 자기공명 이미징(fMRI)과 확산 텐서 이미징(DTI)과 같은 첨단 이미징 기술 개발을 위한 연구개발 활동에 대한 투자가 증가하고 있으며 시장 성장의 원동력이 될 것으로 예상됩니다. 게다가, 개인화된 의료에 대한 관심 증가와 뉴로이미징에서 인공지능(AI)의 통합은 시장 확대의 새로운 길을 제공합니다.
본 조사의 주요 특징
- 본 보고서에서는 세계 뉴로이미징 시장을 상세하게 분석하여 2022년을 기준년으로 한 예측기간(2023-2030년) 시장 규모 및 복합 연간 성장률(CAGR)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고, 이 시장에 대한 매력적인 투자 제안의 행렬을 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 엔터프라이즈 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 세계 뉴로이미징 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계 뉴로이미징 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자들은 세계 뉴로이미징 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제
제2장 시장 전망
- 보고서 설명
- 주요 요약
- Coherent Opportunity Map(COM)
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 화상 기술의 진보
- 고액의 설비 비용
- 맞춤형 의료
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 출시 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
제4장 세계 뉴로이미징 시장 : 코로나바이러스(COVID-19) 팬데믹의 영향
- 신형 코로나 바이러스 감염증(COVID-19)의 역학
- 공급측과 수요측 분석
- 경제적 영향
제5장 세계 뉴로이미징 시장 : 기술별(2023-2030년)
- 자기 공명 영상법(MRI)
- 컴퓨터 단층 촬영(CT)
- 양전자 방출 단층 촬영(PET)
- 단일 광자 방사선 컴퓨터 단층 촬영(SPECT)
- 기능적 자기 공명 영상(fMRI)
- 확산 텐서 이미징(DTI)
- 뇌자도(MEG)
- 뇌파 검사(EEG)
- 기타
제6장 세계 뉴로이미징 시장 : 용도별(2023-2030년)
- 신경학적 장애
- 알츠하이머병
- 파킨슨병
- 다발성 경화증
- 간질
- 뇌졸중
- 기타
- 정신장애
- 정신분열증
- 양극성 장애
- 우울
- 불안장애
- 기타
- 외상성 뇌손상(TBI)
- 뇌종양
- 기타
제7장 세계 뉴로이미징 시장 : 최종 사용자별(2023-2030년)
- 소개
- 병원 및 진료소
- 조사기관
- 외래수술센터(ASC)
- 기타
제8장 세계 뉴로이미징 시장 : 이미지 유형별(2023-2030년)
- 소개
- 구조 이미징
- 기능적 이미징
- 하이브리드 이미징
제9장 세계 뉴로이미징 시장 : 지역별(2023-2030년)
- 소개
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제10장 경쟁 구도
- GE Healthcare
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- Others
제11장 섹션
BJH
영문 목차
The Neuroimaging Market size is expected to reach US$ 56.58 Billion by 2030, from US$ 37.63 Billion in 2023, at a CAGR of 6% during the forecast period.
| Report Coverage |
Report Details |
| Base Year: |
2022 |
Market Size in 2023: |
US$ 37.63 Bn |
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
| Forecast Period 2023 to 2030 CAGR: |
6.00% |
2030 Value Projection: |
US$ 56.58 Bn |
Figure 1. Global Neuroimaging Market Share (%), By Region, 2023
Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underlie various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.
Market Dynamics:
The neuroimaging market is driven by several factors. Firstly, the growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.
However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Additionally, concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.
Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Moreover, the rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.
Key features of the study:
- This report provides in-depth analysis of the global neuroimaging market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroimaging market
Detailed Segmentation:
- By Technology:
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Functional Magnetic Resonance Imaging (fMRI)
- Diffusion Tensor Imaging (DTI)
- Magnetoencephalography (MEG)
- Electroencephalography (EEG)
- Others
- By Application:
- Neurological Disorders
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Brain Tumors
- Others
- By End-User:
- Hospitals and Clinics
- Diagnostic Centers
- Research Institutes
- Ambulatory Surgical Centers
- Others
- By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
- By Image Type:
- Structural Imaging
- Functional Imaging
- Hybrid Imaging
- Top companies in Neuroimaging Market
- GE Healthcare
- Siemens Healthineers
- Philips Healthcare
- Toshiba Medical Systems Corporation
- Hitachi Healthcare
- Canon Medical Systems Corporation
- Mindray Medical International Limited
- Esaote SpA
- NeuroLogica Corporation
- NeuroVive Pharmaceutical AG
- Brainlab AG
- Akili Interactive Labs Inc.
- Brainomix Ltd.
- Imaging Science International
- Mevis Medical Solutions
- NeuroVista
- Neusoft Medical Systems
- Positron Corporation
- Shimadzu Corporation
- Trifoil Imaging
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Technology
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Image Type
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Advancements in Imaging Technology
- High Equipment Costs
- Personalized Medicine
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Neuroimaging Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. Neuroimaging Market , By Technology, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Positron Emission Tomography (PET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Single Photon Emission Computed Tomography (SPECT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Functional Magnetic Resonance Imaging (fMRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Diffusion Tensor Imaging (DTI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Magnetoencephalography (MEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Electroencephalography (EEG)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
6. Neuroimaging Market , By Application, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Epilepsy
- Stroke
- Others
- Psychiatric Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Schizophrenia
- Bipolar Disorder
- Depression
- Anxiety Disorders
- Others
- Traumatic Brain Injury (TBI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Brain Tumors
- Others
7. Neuroimaging Market , By End User, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
8. Neuroimaging Market , By Image Type, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
- Structural Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Functional Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
- Hybrid Imaging
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Billion)
9. Neuroimaging Market , By Region, 2023-2030, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2018 -2030
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Image Type, 2023-2030,(US$ Bn)
10. Competitive Landscape
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Philips Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Toshiba Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Esaote SpA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- NeuroLogica Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Others
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
11. Section
- Research Methodology
- About us
관련자료
